Biophage Pharma appoints two new members to the board of directors
Montreal, July 16, 2008 - (TSX.V: BUG). Biophage
Pharma is pleased to announce the appointment of Mr. Luc Dubois and Mr. Jocelyn
R. Pelchat to its Board of Directors. Mr. Dubois is the Presi...
Superbugs vs. Superdrugs: Race Goes On
GEN, Jun 1 2008 (Vol. 28, No. 11)
Development of Antibacterial Therapies Needs to Take a Front-Row Seat in the Research Arena
Sue Pearson, Ph.D.
At the recent “Superbugs an...
Biophage Pharma announces sale of Immunotox Labs division to Validapro Biosciences Inc
Montreal, May 16, 2008 (TSX.V: BUG) - Biophage Pharma today announced that it has sold the assets of its Immunotox Labs Division to Validapro BioSciences Inc. for an aggregate consideration of $400,...
Biophage announces a resignation
MONTREAL, May 13 - (TSX.V: BUG) - Biophage Pharma today
announced that Dr Robert Burr has resigned as member of the Company board of
directors. "I would like to extent the ap...
Biophage Pharma corporate update
MONTREAL, March 28 - (TSX.V: BUG) Biophage Pharma Inc. (the
"Corporation") reports today that over the past months, the Corporation was
actively seeking to increase revenues...
Home 